Search
N-oleoyldopamine
go.drugbank.com/drugs/DB17036ExperimentalN-oleoyldopamine (OLDA) is an amide of dopamine and oleic acid.[A253042]
Synonyms: N-oleoyldopamine, (9z)- n-(2-(3,4-dihydroxyphenyl)ethyl)-9-octadecenamidePI-103
go.drugbank.com/drugs/DB17046ExperimentalPI-103 is an inhibitor of p110α of class I PI3K.[A253092]
SRT-1720
go.drugbank.com/drugs/DB17057ExperimentalSRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.[A253147]
Synonyms: 2-quinoxalinecarboxamide, n-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-, N-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamideEdralbrutinib
go.drugbank.com/drugs/DB18095InvestigationalEdralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.
VCN-01
go.drugbank.com/drugs/DB18193InvestigationalVCN-01 is an investigational, genetically modified human adenovirus encoding human PH20.
(5E,7E,9)-decatrien-2-one
go.drugbank.com/drugs/DB15618ExperimentalAn compound produced by _Fomitopsis betulina_, an edible fungus commonly called the birch polypore. Similar to [(5Z,7E,9)-decatrien-2-one], it has a strong pineapple aroma.[A191116]
LX-7101
go.drugbank.com/drugs/DB16009InvestigationalLX-7101 is under investigation in clinical trial NCT01528111 (Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension).
TRO40303
go.drugbank.com/drugs/DB16031InvestigationalTRO40303 is under investigation in clinical trial NCT01374321 (Safety and Efficacy Study of TRO40303 for Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute
PF-06882961
go.drugbank.com/drugs/DB16043InvestigationalPF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).
2'-Fucosyllactose
go.drugbank.com/drugs/DB16052Investigational2'-Fucosyllactose is under investigation in clinical trial NCT03847467 (Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-tnf Therapy).